Home/Filings/4/0001610717-23-000361
4//SEC Filing

Wilbur James 4

Accession 0001610717-23-000361

CIK 0001770787other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 4:30 PM ET

Size

5.0 KB

Accession

0001610717-23-000361

Insider Transaction Report

Form 4
Period: 2023-11-20
Wilbur James
Chief Commercial Officer
Transactions
  • Sale

    Class A Common Stock

    2023-11-20$42.09/sh14,718$619,49486,806 total
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $42.05 to $42.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  • [F2]Includes 271 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 14, 2023.

Documents

1 file

Issuer

10x Genomics, Inc.

CIK 0001770787

Entity typeother

Related Parties

1
  • filerCIK 0001940931

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:30 PM ET
Size
5.0 KB